IBRX
NASDAQ · Biotechnology
Immunitybio Inc
$8.51
+0.75 (+9.66%)
Performance
1D
—
1W
—
1M
—
3M
+22.80%
6M
+297.66%
1Y
+260.59%
YTD
+321.29%
Open$7.88
Previous Close$7.76
Day High$8.56
Day Low$7.58
52W High$12.43
52W Low$1.83
Volume—
Avg Volume12.23M
Market Cap8.72B
P/E Ratio—
EPS$-0.39
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$4.22
Above
SMA 200
$2.95
Above
RSI (14)
70.9
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
11 analysts
Price Target
+1,178.4% upside
Current
$8.51
$8.51
Target
$108.79
$108.79
$71.54
$108.79 avg
$142.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 126.29M | 1.55B | 1.61B |
| Net Income | -391,584,833 | 174.18M | 206.87M |
| Profit Margin | -310.2% | 11.2% | 12.9% |
| EBITDA | -211,271,293 | 310.76M | 319.11M |
| Free Cash Flow | — | 125.72M | 219.44M |
| Rev Growth | +678.6% | +14.4% | +15.1% |
| Debt/Equity | 0.01 | 0.68 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |